GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, got off to a successful start in fiscal 2016, with double-digit gains in sales revenue and earnings1. “We continue to see dynamic growth driven by both divisions and all business regions,” commented CEO Dr. Joachim Kreuzburg. “Especially our larger Bioprocess Solutions Division has continued to perform excellently; regionally, business in the Americas has been expanding the most as projected. Based on our first-quarter results, we confirm our ambitious targets that we have set for the full year of 2016.”
